U.S. FDA issues recall of Ethicon’s surgical staplers
The U.S. Food and Drug Administration issued a recall of surgical staplers made by Johnson & Johnson’s Ethicon unit, warning that the use of the devices could cause serious injury or death.
Featured Posts
Pharma Innovators Special Feature 2018: Focus on innovation
In seeking innovative players that could change pharma and healthcare, Med Ad News found the developer of an app that helps people determine what illnesses are in their neighborhoods; the creator of a wearable injector that allows patients on biologics to receive these drugs outside the clinic; and a designer of a deep learning network aimed at giving pharma and healthcare companies a handle on their data.
2015 U.S. trends in aggregate spend, disclosure, and transparency
What are key trends in the transparency compliance landscape? And, how are life sciences manufacturers tackling growing requirements
Future of Healthcare
I got into Healthcare six years ago and canvassed major events to gain a consensus on what the future held.
J&J agrees to pay about $1 billion to resolve hip implant lawsuits: Bloomberg
Johnson & Johnson agreed to pay about $1 billion to resolve the bulk of lawsuits claiming the company sold defective metal-on-metal hip implants that ultimately had to be removed, Bloomberg reported, citing people with knowledge of the matter.
GSK’s 3-in-1 inhalable drug shows promise in asthma study
GlaxoSmithKline Plc said the company’s three-in-one drug Trelegy Ellipta met the main goal of a late-stage asthma study, signaling a possible boost to the British drugmaker’s lung medicines division.
Reports: Odds of Getting Drugs to Market Range from 6% to 40%
A recent report written by SVB Leerink analysts that looked at eight companies and their research-and-development portfolios found that in the past five years, they progressed only 24 percent of their new molecular entities to approval.
Abbott, the U.S. Department of Defense and TRACK-TBI Partner to Study Point-of-Care Blood Test for Concussions
Abbott announced the next phase of partnership with the U.S. Department of Defense and researchers from the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Network, one of the largest traumatic brain injury efforts of its kind.
3D goggles may soon help surgeons see better
In a first, heart surgeons in Poland used 3D goggles to help them see inside a patient’s chest as they opened up a narrowed heart valve, according to a report in the European Heart Journal.
March Madness: “The Fabulous 5” Life Science IPOs
March 2019 was a busy month for biopharma and medical device company initial public offerings.
Integra gets FDA warning letter for Boston plant
Integra Lifesciences Holdings Corp. received a warning letter from the U.S. Food and Drug Administration regarding the medical device maker ‘s manufacturing facility in Boston.
FDA Grants Breakthrough Designation to Paige.AI
Paige.AI was granted Breakthrough Device designation by the U.S. Food and Drug Administration, the first such designation for AI in cancer diagnosis publicly announced by any company.
Ad Right Top
MedAdNews
Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com. 
April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!